European equities investment outperforms index after 3 months of rises (LON:FEV)

fidelity-logo

Fidelity European Trust PLC (LON:FEV) monthly factsheet for the period ended 31 January 2024.

Portfolio Manager Commentary

Continental European equities rose for a third consecutive month as investors drew comfort from upbeat corporate results and anticipated interest rate cuts by major central banks. As expected, the European Central Bank maintained its key interest rate at 4.0% and indicated that it is likely to implement its first rate cut in the Summer, whilst emphasizing the need for more evidence of disinflation to justify a more accommodative policy.

During the month, the Trust outperformed the index. Security selection in the information technology and health care sectors, coupled with strong performance of technology holdings drove gains. At a stock level, Dutch semiconductor business ASML rose on the back of strong Q4’23 results and a growing order backlog. SAP advanced on upbeat results for Q4 and FY2023, and encouraging guidance for FY2024 driven by acceleration in its key cloud business. Conversely, weaker performance of financials and consumer discretionary stocks held back gains. German sportswear business Puma was the biggest relative detractor. Shares fell after the company’s FY2023 net profit modestly disappointed and guidance for FY2024 growth came in below consensus.

Our focus is on finding attractively valued companies with good prospects for cash generation and dividend growth over the longer term. On a rolling 12-month basis, the Trust recorded NAV and
share price returns of 11.2% and 9.8% respectively, compared to 8.8% for the index.

Fidelity European Trust PLC (LON:FEV) is a European investment trust. It  aims to be the cornerstone long-term investment of choice for those seeking European exposure across market cycles.

Share on:
Find more news, interviews, share price & company profile here for:

Investing in Europe: Why investors should remain positive

Co-Portfolio Manager of the Fidelity European Trust PLC (LON:FEV), outlines why he believes quality businesses backed by strong balance sheets and dividend growth potential remain well placed to deliver strong relative returns over the long-term.

Fidelity European Trust rises in August, reporting 16.4% returns in 2025

Fidelity European Trust highlighted strong contributions in August 2025 from KBC Groupe, which upgraded full year guidance, and Novo Nordisk, which advanced on positive trial results and regulatory approval for Wegovy.

Fidelity European Trust Factsheet – July volatility, Legrand and Bankinter gains

Continental European equities were volatile in July, with the Trust underperforming the index due to weak stock selection in financials and healthcare. Novo Nordisk and ASML detracted, while Legrand and Bankinter contributed positively. Over 12 months, the Trust’s NAV rose 1.8% and the share price 1.7%, compared with an 11.3% gain for the index.

European Investment Opportunities – Fidelity’s Quality Focus (LON:FEV)

FEV portfolio manager Marcel Stotzel highlights how quality companies with strong defensive characteristics can help investors navigate uncertainty and achieve long-term growth.

16.7% YTD return hails Fidelity European Trust’s strong credentials

Despite market headwinds, the Trust demonstrated resilience with standout contributions from Legrand and EQT and positive sector positioning. Over the past 12 months, NAV rose 2.3% and share price 5.5%, reflecting our focus on cash‑generative, dividend‑growing companies.

Fidelity European Trust May Factsheet – European equities moved higher

European equities rose in May amid volatility linked to US trade uncertainty. Fidelity European Trust underperformed the index, mainly due to weak positions in consumer sectors.

Search

Search